The current institutional shareholding score of Marker Therapeutics Inc is 3.00, ranking 192 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 26.04%, representing a quarter-over-quarter increase of 17.09%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.05% of shares outstanding, with 0.13% decrease in holdings.